TAKEDA PHARMACEUTICAL CO LTD's ticker is TAK and the CUSIP is 874060205. A total of 3 filers reported holding TAKEDA PHARMACEUTICAL CO LTD in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $988,162 | +9.9% | 63,876 | +11.6% | 0.02% | +16.7% |
Q2 2023 | $899,366 | -29.1% | 57,248 | -25.6% | 0.02% | -30.8% |
Q1 2023 | $1,268,268 | +17.0% | 76,958 | +10.8% | 0.03% | +18.2% |
Q4 2022 | $1,083,779 | +8.1% | 69,473 | -10.2% | 0.02% | +4.8% |
Q3 2022 | $1,003,000 | +4.4% | 77,360 | +13.1% | 0.02% | +16.7% |
Q2 2022 | $961,000 | -15.3% | 68,420 | -13.7% | 0.02% | +5.9% |
Q1 2022 | $1,135,000 | +39.8% | 79,263 | +33.1% | 0.02% | +41.7% |
Q4 2021 | $812,000 | -21.2% | 59,563 | -5.3% | 0.01% | -25.0% |
Q3 2021 | $1,030,000 | +14.2% | 62,884 | +17.3% | 0.02% | +23.1% |
Q2 2021 | $902,000 | +12.8% | 53,607 | +22.4% | 0.01% | +8.3% |
Q1 2021 | $800,000 | +79.4% | 43,796 | +78.6% | 0.01% | +71.4% |
Q4 2020 | $446,000 | +48.2% | 24,528 | +45.3% | 0.01% | +16.7% |
Q3 2020 | $301,000 | +246.0% | 16,878 | +247.7% | 0.01% | +200.0% |
Q2 2020 | $87,000 | – | 4,854 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
TFG Asset Management GP Ltd | 1,903,662 | $29,449,652 | 5.37% |
MANAGED ASSET PORTFOLIOS, LLC | 1,736,416 | $26,862,356 | 4.12% |
Y.D. More Investments Ltd | 1,381,550 | $21,372,579 | 4.11% |
Clean Yield Group | 533,157 | $8,167,965 | 3.62% |
XY Capital Ltd | 143,697 | $2,222,993 | 1.28% |
Mondrian Investment Partners LTD | 4,081,715 | $61,225,725 | 1.26% |
Capricorn Fund Managers Ltd | 204,892 | $3,169,679 | 1.10% |
Legacy Wealth Asset Management, LLC | 124,967 | $1,933,239 | 0.71% |
HAP Trading, LLC | 263,679 | $4,079,114 | 0.65% |
BRANDES INVESTMENT PARTNERS, LP | 1,802,036 | $27,877,493 | 0.54% |